Two Sigma Investments’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-170,136
Closed -$517K 3528
2024
Q4
$517K Buy
170,136
+13,539
+9% +$41.2K ﹤0.01% 2463
2024
Q3
$813K Sell
156,597
-477,306
-75% -$2.48M ﹤0.01% 2176
2024
Q2
$1.63M Buy
633,903
+376,506
+146% +$968K ﹤0.01% 1621
2024
Q1
$1.27M Buy
+257,397
New +$1.27M ﹤0.01% 1731
2023
Q3
Sell
-816,839
Closed -$20.7M 3200
2023
Q2
$20.7M Sell
816,839
-557,499
-41% -$14.1M 0.05% 372
2023
Q1
$44.3M Buy
1,374,338
+23,184
+2% +$747K 0.13% 186
2022
Q4
$24.9M Buy
1,351,154
+229,331
+20% +$4.23M 0.08% 279
2022
Q3
$30.3M Buy
1,121,823
+777,135
+225% +$21M 0.1% 239
2022
Q2
$4.76M Buy
344,688
+235,292
+215% +$3.25M 0.02% 767
2022
Q1
$2.13M Buy
109,396
+20,590
+23% +$401K 0.01% 1291
2021
Q4
$1.45M Buy
+88,806
New +$1.45M ﹤0.01% 1490
2020
Q4
Sell
-32,722
Closed -$823K 2512
2020
Q3
$823K Buy
32,722
+19,613
+150% +$493K ﹤0.01% 1245
2020
Q2
$320K Sell
13,109
-114,858
-90% -$2.8M ﹤0.01% 1591
2020
Q1
$1.89M Buy
127,967
+76,065
+147% +$1.13M 0.02% 706
2019
Q4
$842K Buy
+51,902
New +$842K ﹤0.01% 1483
2019
Q3
Sell
-36,242
Closed -$470K 2442
2019
Q2
$470K Sell
36,242
-80,770
-69% -$1.05M ﹤0.01% 1613
2019
Q1
$1.84M Buy
+117,012
New +$1.84M 0.01% 1193
2018
Q4
Sell
-39,039
Closed -$970K 2496
2018
Q3
$970K Sell
39,039
-106,638
-73% -$2.65M ﹤0.01% 1376
2018
Q2
$4M Buy
145,677
+97,822
+204% +$2.69M 0.01% 807
2018
Q1
$1.47M Sell
47,855
-36,287
-43% -$1.12M ﹤0.01% 1178
2017
Q4
$3.01M Buy
+84,142
New +$3.01M 0.01% 986
2016
Q1
Sell
-48,146
Closed -$1.65M 2416
2015
Q4
$1.65M Buy
+48,146
New +$1.65M 0.01% 1031
2015
Q2
Sell
-51,673
Closed -$1.07M 2458
2015
Q1
$1.07M Buy
+51,673
New +$1.07M 0.01% 1357